Norway Ai In Oncology Market Size & Outlook, 2026-2033

The ai in oncology market in Norway is expected to reach a projected revenue of US$ 595.8 million by 2033. A compound annual growth rate of 24.6% is expected of Norway ai in oncology market from 2026 to 2033.
Revenue, 2025 (US$M)
$92.8
Forecast, 2033 (US$M)
$595.8
CAGR, 2026 - 2033
24.6%
Report Coverage
Norway

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Norway ai in oncology market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Norway ai in oncology market highlights

  • The Norway ai in oncology market generated a revenue of USD 92.8 million in 2025 and is expected to reach USD 595.8 million by 2033.
  • The Norway market is expected to grow at a CAGR of 24.6% from 2026 to 2033.
  • In terms of segment, hardware was the largest revenue generating component in 2025.
  • Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.


Ai in oncology market data book summary

Market revenue in 2025USD 92.8 million
Market revenue in 2033USD 595.8 million
Growth rate24.6% (CAGR from 2026 to 2033)
Largest segmentHardware
Fastest growing segmentSoftware Solutions
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationHardware, Software Solutions, Services
Key market players worldwideInternational Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp


Other key industry trends

  • In terms of revenue, Norway accounted for 1.5% of the global ai in oncology market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany ai in oncology market is projected to lead the regional market in terms of revenue in 2033.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 1,178.4 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

AI In Oncology Market Companies

Name Profile # Employees HQ Website
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
NVIDIA Corp View profile 29600 2788 San Tomas Expressway, Santa Clara, CA, United States, 95051 https://www.nvidia.com
International Business Machines Corp View profile 282200 One New Orchard Road, Armonk, NY, United States, 10504 http://www.ibm.com
Intel Corp View profile 124800 2200 Mission College Boulevard, Santa Clara, CA, United States, 95054-1549 https://www.intel.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

Norway ai in oncology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.


Hardware was the largest segment with a revenue share of 55.06% in 2025. Horizon Databook has segmented the Norway ai in oncology market based on hardware, software solutions, services covering the revenue growth of each sub-segment from 2021 to 2033.


The AI in oncology market in Norway is driven by partnerships, product launches, and several other business initiatives, as well as various research studies being conducted to explore the potential of AI in various aspects of cancer treatment.

Furthermore, the active support from regulatory agencies and healthcare institutions is instrumental in propelling AI integration, as evidenced by the implementation of pilot programs and the provision of funding for research and development.

Furthermore, in July 2019, NEC Corporation acquired Onco Immunity AS, a bioinformatics company that develops ML software to support cancer therapy development. Onco Immunity AS became a NEC subsidiary and operated under the name of NEC Onco Immunity AS.

Reasons to subscribe to Norway ai in oncology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Norway ai in oncology market databook

  • Our clientele includes a mix of ai in oncology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Norway ai in oncology market , including forecasts for subscribers. This country databook contains high-level insights into Norway ai in oncology market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Norway ai in oncology market size, by component, 2021-2033 (US$M)

Norway AI In Oncology Market Outlook Share, 2025 & 2033 (US$M)

Norway ai in oncology market size, by component, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online